Hormone Therapy For Menopause
by Groshan Fabiola on 2007-09-22
A study from 2002, named Women's Health Initiative study sustained that hormone replacement therapy is related life-threatening risks such as heart attack, strokes or even cancer.
Women were worried and more than 65 % of them gave up the treatment.
Specialists still believed that hormone therapy is effective and it does not involve many as risks as the Women's Health Initiative study concluded.
Dr. Shelley R. Salpeter, MD, a clinical professor of medicine at Stanford University's School of Medicine said that after a study she had concluded that hormone therapy can prevent heart disease, hip fractures and osteoporosis and that it cuts the risk of developing diabetes by 30 %in younger women. She also agreed that the risk of heart attacks among the women that get hormone replacement therapy is reduced with 32 % for women that have not passed 60. The results were compared to those of the women that did not receive hormone replacement therapy.
Dr. Salpeter’s study also indicated that age is a very important factor for women that get hormone replacement therapy. She sustains that hormone replacement therapy leads to an increased risk of blood clots if hormone therapy is the first treatment. She also says that for healthy women that are under 50 but close to menopause the mentioned risk is very unlikely to cause problems. Even if specialists do not agree with her she sustains that the higher risk subsides after a couple of years.
Women over 60 are more likely to develop heart diseases. In their case the risk of blood clots becomes more serious. So, a woman that begins her hormone replacement therapy after the age of 60, exposes to much higher risks.
Salpeter results affected the Women's Health Initiative trial. Salpeter believed that the researchers were looking at many women that might already have been sick. It was also noticed that the average age of a woman in that trial was 63.
Everyone agreed that Women's Health Initiative study was wrong because they were looking at the wrong group of people. Specialists also said that WHI results have done nothing but falsely alarmed women all over the world.
It was proved that menopausal women that take estrogen appear to have a lower risk of developing breast cancer than women that take progestin and estrogen together. A JAMA article also concluded that after seven years of treatment with estrogen there seemed to be no increase of the risk for breast cancer.
Women were worried and more than 65 % of them gave up the treatment.
Specialists still believed that hormone therapy is effective and it does not involve many as risks as the Women's Health Initiative study concluded.
Dr. Shelley R. Salpeter, MD, a clinical professor of medicine at Stanford University's School of Medicine said that after a study she had concluded that hormone therapy can prevent heart disease, hip fractures and osteoporosis and that it cuts the risk of developing diabetes by 30 %in younger women. She also agreed that the risk of heart attacks among the women that get hormone replacement therapy is reduced with 32 % for women that have not passed 60. The results were compared to those of the women that did not receive hormone replacement therapy.
Dr. Salpeter’s study also indicated that age is a very important factor for women that get hormone replacement therapy. She sustains that hormone replacement therapy leads to an increased risk of blood clots if hormone therapy is the first treatment. She also says that for healthy women that are under 50 but close to menopause the mentioned risk is very unlikely to cause problems. Even if specialists do not agree with her she sustains that the higher risk subsides after a couple of years.
Women over 60 are more likely to develop heart diseases. In their case the risk of blood clots becomes more serious. So, a woman that begins her hormone replacement therapy after the age of 60, exposes to much higher risks.
Salpeter results affected the Women's Health Initiative trial. Salpeter believed that the researchers were looking at many women that might already have been sick. It was also noticed that the average age of a woman in that trial was 63.
Everyone agreed that Women's Health Initiative study was wrong because they were looking at the wrong group of people. Specialists also said that WHI results have done nothing but falsely alarmed women all over the world.
It was proved that menopausal women that take estrogen appear to have a lower risk of developing breast cancer than women that take progestin and estrogen together. A JAMA article also concluded that after seven years of treatment with estrogen there seemed to be no increase of the risk for breast cancer.
About The Author: For more resources about menopause or about menopause symptoms please review www.menopause-info-guide.com/menopause-symptoms.htm